TP53 and myxoid liposarcoma: TP53 mutations were prevalent in 9 out of 10 (90%) myxoid liposarcomas, while they were less frequent in other subtypes (7.7% of well-differentiated, 37.5% of pleomorphic, and 14.3% of dedifferentiated cases).